NEW YORK, NY--(Marketwire - Nov 8, 2012) - Companies in the wholesale drug industry, such as AmerisourceBergen and McKesson, have been doing an admirable job of late. Sales for many companies in the industry have contracted in recent quarterly reports, as the impact of lower priced generics take their toll. However, earnings have not followed the same trend in some cases, as select companies have effectively cut costs and improved margins. StBulls.com initiated technical analysis on AmerisourceBergen Corporation (NYSE: ABC) and McKesson Corp. (NYSE: MCK). These reports are free upon registration at
www.StBulls.com enthuses to bring the best from the internet under one roof, providing you with a one click opportunity to view what the market and financial researchers globally have to say about any particular bellwether stocks in any given financial environment. Sign up now at
With the major shift from brand-to-generic drugs continuing, companies that have a diversified portfolio of products could be better equipped to deal with the continued patent expirations. A wide range of product offerings are also a plus during times of economic uncertainty, as companies do not have to rely on the success of only a handful of products. In recent weeks, Drug wholesaler McKesson made steadfast their decision to acquire PSS World Medical in a bid to boost its portfolio of medical supplies and to develop its distribution. Our technical analysis on McKesson is available at
Also working in favor of the industry is the ageing baby-boomer population. The U.S. is currently witnessing 10,000 baby boomers per day crossing the 65-year-old mark, and this trend will continue for more than fifteen years. With older people generally requiring more medical attention, the industry could be well positioned for growth moving forward. Companies like AmerisourceBergen should also be able to take full advantage of the expanded healthcare coverage. Read our technical analysis on AmerisourceBergen at
About Street Bulls
STREET BULLS is committed to provide the investor community with sharp and timely trading and investing advice. Our aim is to help our readers achieve above-average returns from the markets and create wealth for themselves. Our newsletters and trading advice will provide investors with the information they need for success in today's volatile markets.
To view our disclaimer, use this link